ADCNF
Adicon Holdings Limited, an investment holding company, provides medical testing services in the People's Republic of China. The company offers medical diagnostic testing services; testing services for research and development projects; and research and clinical trial services. It also engages in the trading of medical testing equipment; and sale of medical products. The company was founded in 20… Read more
ADCNF (ADCNF) - Total Assets
Latest total assets as of June 2025: $4.51 Billion USD
Based on the latest financial reports, ADCNF (ADCNF) holds total assets worth $4.51 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ADCNF - Total Assets Trend (2021–2025)
This chart illustrates how ADCNF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ADCNF - Asset Composition Analysis
Current Asset Composition (June 2025)
ADCNF's total assets of $4.51 Billion consist of 65.1% current assets and 34.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 22.3% |
| Accounts Receivable | $1.75 Billion | 37.3% |
| Inventory | $126.94 Million | 2.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $154.06 Million | 3.3% |
| Goodwill | $79.80 Million | 1.7% |
Asset Composition Trend (2021–2025)
This chart illustrates how ADCNF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ADCNF's current assets represent 65.1% of total assets in 2025, a decrease from 85.7% in 2021.
- Cash Position: Cash and equivalents constituted 22.3% of total assets in 2025, down from 45.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 37.3% of total assets.
ADCNF Competitors by Total Assets
Key competitors of ADCNF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.47 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
ADCNF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - ADCNF generates 0.62x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, ADCNF generates $ 1.00 in net profit.
ADCNF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 1.99 | 1.61 |
| Quick Ratio | 1.51 | 1.91 | 1.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.06 Billion | $ 1.57 Billion | $ 1.48 Billion |
ADCNF - Advanced Valuation Insights
This section examines the relationship between ADCNF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.03 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | $4.69 Billion |
| Market Capitalization | $172.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values ADCNF's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: ADCNF's assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for ADCNF (2021–2025)
The table below shows the annual total assets of ADCNF from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $4.69 Billion | +2.89% |
| 2024-06-30 | $4.55 Billion | -6.19% |
| 2023-06-30 | $4.85 Billion | +56.09% |
| 2022-06-30 | $3.11 Billion | +14.18% |
| 2021-06-30 | $2.72 Billion | -- |